Trial reportBMC anesthesiology2026
Association between pericapsular nerve group (PENG) block and postoperative inflammatory indices and analgesic outcomes in total hip arthroplasty: a randomized controlled trial.
Trial report in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07023107 (Pericapsular Nerve Group Block Mitigates Surgical Stress and Enhances Analgesia in Total Hip Arthroplasty), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Pericapsular Nerve Group Block Mitigates Surgical Stress and Enhances Analgesia in Total Hip Arthroplasty: A Randomized Controlled Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTotal hip arthroplasty (THA) induces a pronounced postoperative inflammatory response that contributes to pain, increased opioid requirements, and delayed recovery, particularly in older adults. Although the pericapsular nerve group (PENG) block provides effective analgesia, its impact on systemic inflammation remains insufficiently defined.
methodsIn this prospective, randomized, quadruple-blinded controlled trial, patients aged ≥ 60 years undergoing elective unilateral THA performed under spinal anesthesia were randomized (1:1) to receive an ultrasound-guided PENG block with ropivacaine or a sham block. The primary outcome was the neutrophil-to-lymphocyte ratio (NLR) at 12 h postoperatively. Secondary outcomes included platelet-to-lymphocyte ratio (PLR) at 12, 24, and 48 h, postoperative pain scores, time to first opioid administration, and cumulative opioid consumption within 48 h.
resultsSixty patients completed the study (30 per group). Baseline inflammatory markers were comparable between groups. At 12 h, NLR was significantly lower in the PENG group than in the control group (5.98 ± 1.42 vs. 9.60 ± 1.83; adjusted p < 0.0001), with sustained reductions at 24 h (2.47 ± 0.77 vs. 5.71 ± 1.74; adjusted p < 0.0001) and 48 h (1.84 ± 0.71 vs. 3.53 ± 1.08; adjusted p < 0.0001). PLR was also significantly lower in the PENG group at all postoperative time points (all adjusted p < 0.0001), with a significantly different postoperative trajectory between groups over time. The PENG block significantly prolonged time to first opioid administration (15.0 ± 1.5 vs. 9.3 ± 1.7 h; p < 0.001) and reduced cumulative 48-h opioid consumption (13.2 ± 2.7 vs. 20.8 ± 3.2 mg; p < 0.001). Pain scores at rest and during mobilization were consistently lower in the PENG group throughout the first 24 h.
conclusionsIn older adults undergoing THA, the PENG block was associated with lower postoperative inflammatory indices, improved pain control, and reduced opioid requirements. Because NLR and PLR are indirect inflammatory markers, these findings should be interpreted cautiously and viewed as associative rather than mechanistic. Further studies are required to determine whether these physiological differences translate into improved clinical recovery outcomes.
trial registrationClinicalTrials.gov (NCT07023107), registered on 8 June 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.